Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1996 1
2001 1
2003 1
2006 1
2014 1
2015 1
2017 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Adiponectin promotes preadipocyte differentiation via the PPARγ pathway.
Yang W, Yang C, Luo J, Wei Y, Wang W, Zhong Y. Yang W, et al. Mol Med Rep. 2018 Jan;17(1):428-435. doi: 10.3892/mmr.2017.7881. Epub 2017 Oct 26. Mol Med Rep. 2018. PMID: 29115433
After 8 days, an MTT assay was used to examine cell viability and oil red O staining was used to observe preadipocyte differentiation. In addition, the mRNA expression levels of monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-6, IL-8 and tumor
After 8 days, an MTT assay was used to examine cell viability and oil red O staining was used to observe preadipocyte differentiation. In ad …
CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes.
Wedel A, Sulski G, Ziegler-Heitbrock HW. Wedel A, et al. Cytokine. 1996 May;8(5):335-41. doi: 10.1006/cyto.1996.0046. Cytokine. 1996. PMID: 8726660
Within the human TNF promoter we have identified two sites at positions -189 and -101 that show C/EBP specific binding of nuclear proteins from cells of the human monocytic line Mono Mac 6. ...Hence, the data indicate that the -101 C/EBP motif i …
Within the human TNF promoter we have identified two sites at positions -189 and -101 that show C/EBP specific binding of nucl …
Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP).
Ron D, Brasier AR, McGehee RE Jr, Habener JF. Ron D, et al. J Clin Invest. 1992 Jan;89(1):223-33. doi: 10.1172/JCI115566. J Clin Invest. 1992. PMID: 1729273 Free PMC article.
Lipopolysaccharide-treated monocyte-conditioned medium or recombinant human TNF alpha induced morphological dedifferentiation of the adipocytes and led to loss of adipocyte specific gene expression. Gel shift, Southwestern and Western immunoblot …
Lipopolysaccharide-treated monocyte-conditioned medium or recombinant human TNF alpha induced morphological dedifferent …
Transcriptional inhibition of interleukin-8 expression in tumor necrosis factor-tolerant cells: evidence for involvement of C/EBP beta.
Weber M, Sydlik C, Quirling M, Nothdurfter C, Zwergal A, Heiss P, Bell S, Neumeier D, Ziegler-Heitbrock HW, Brand K. Weber M, et al. J Biol Chem. 2003 Jun 27;278(26):23586-93. doi: 10.1074/jbc.M211646200. Epub 2003 Apr 21. J Biol Chem. 2003. PMID: 12707271 Free article.
There is some evidence that the potent cytokine tumor necrosis factor (TNF) is able to induce tolerance after repeated stimulation of cells. ...Remarkably, in tolerant cells an increased binding of C/EBPbeta to its IL-8 promoter-specific DNA motif as w …
There is some evidence that the potent cytokine tumor necrosis factor (TNF) is able to induce tolerance after repeated …
Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6.
Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H, Kishimoto T. Natsuka S, et al. Blood. 1992 Jan 15;79(2):460-6. Blood. 1992. PMID: 1730090
NF-IL6 was originally identified as a DNA binding protein regulating interleukin-1 (IL-1)-stimulated IL-6 expression. ...Particularly in HL-60 cells that undergo granulocyte or macrophage differentiation depending on inducers, NF-IL6 mRNA was specifically upr …
NF-IL6 was originally identified as a DNA binding protein regulating interleukin-1 (IL-1)-stimulated IL-6 expression. . …
Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulators involved.
Dusi S, Donini M, Lissandrini D, Mazzi P, Bianca VD, Rossi F. Dusi S, et al. Eur J Immunol. 2001 Mar;31(3):929-38. doi: 10.1002/1521-4141(200103)31:3<929::aid-immu929>3.0.co;2-m. Eur J Immunol. 2001. PMID: 11241298 Free article.
However, in presence of IFN-gamma or TNF-alpha, the superoxide anion (O(2)(-)) production, the p47phox, gp91phox and p22phox expression, and the binding of PU.1 and CP-1 to DNA are maintained at the high levels observed in blood monocytes. ...Our resul …
However, in presence of IFN-gamma or TNF-alpha, the superoxide anion (O(2)(-)) production, the p47phox, gp91phox and p22phox expre
Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease.
Friedrich M, Diegelmann J, Schauber J, Auernhammer CJ, Brand S. Friedrich M, et al. Mucosal Immunol. 2015 Jul;8(4):943-58. doi: 10.1038/mi.2014.124. Epub 2014 Dec 10. Mucosal Immunol. 2015. PMID: 25492478
Serum IL-17C levels are modified by IL23R genotypes and IL-17C mRNA correlates (r>0.5, P<0.001) with IL-17A, tumor necrosis factor (TNF)-alpha, C-C motif chemokine ligand 20 (CCL20) and IL-23 mRNA in the inflamed colon of IBD patients. In the inf …
Serum IL-17C levels are modified by IL23R genotypes and IL-17C mRNA correlates (r>0.5, P<0.001) with IL-17A, tumor necrosis
Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes.
Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R, Bäuerle P, Ströbel M. Ziegler-Heitbrock HW, et al. J Immunol. 1993 Dec 15;151(12):6986-93. J Immunol. 1993. PMID: 8258705
The human TNF promoter contains four potential nuclear factor-kappa B (NF-kappa B)-binding sites, with the strongest binding seen for the -605 motif. ...These data show that dithiocarbamates can profoundly affect cytokine expression and suggest …
The human TNF promoter contains four potential nuclear factor-kappa B (NF-kappa B)-binding sites, with the strongest …
C/EBP beta blocks p65 phosphorylation and thereby NF-kappa B-mediated transcription in TNF-tolerant cells.
Zwergal A, Quirling M, Saugel B, Huth KC, Sydlik C, Poli V, Neumeier D, Ziegler-Heitbrock HW, Brand K. Zwergal A, et al. J Immunol. 2006 Jul 1;177(1):665-72. doi: 10.4049/jimmunol.177.1.665. J Immunol. 2006. PMID: 16785565 Free article.
Earlier experiments in TNF-tolerant cells display inhibition of NF-kappaB-dependent IL-8 gene expression at the transcriptional level with potential involvement of C/EBPbeta. ...These results define a new molecular mechanism responsible for TNF tolerance in …
Earlier experiments in TNF-tolerant cells display inhibition of NF-kappaB-dependent IL-8 gene expression at the transcriptiona …